Common Ketamine Questions: Evidence, Prescriptions, and Follow-Up
Answers to common questions about ketamine formulations, evidence, existing medications, progress checks, and the importance of an individualized contact and emergency plan.
Share
People considering ketamine often want straightforward answers about what it is, who might discuss it with a clinician, and how follow-up works. The most useful answers distinguish the medication, the treatment setting, and the evidence behind a proposed plan.
Important: Compounded ketamine is not FDA-approved. FDA has not reviewed these products for safety, effectiveness, or quality before marketing. Ketamine is not FDA-approved for psychiatric conditions. Compounded nasal spray is different from FDA-approved esketamine (Spravato), which is administered in certified healthcare settings. Read FDA's explanation of compounded drugs.
Is ketamine one standardized depression treatment?
No. “Ketamine therapy” can refer to different formulations and routes. Intravenous ketamine, compounded oral or nasal medication, and FDA-approved esketamine should not be treated as interchangeable. Ask exactly what is proposed and which evidence supports it for your diagnosis.
Does everyone improve?
No. Improvement is uncertain, and a dramatic testimonial does not predict your result. A study's outcomes depend on its participants, medication, route, comparator, and follow-up. Results from an intravenous or esketamine study do not establish an expected success rate for compounded at-home spray.
Can I continue my other medication?
Give the clinician a complete list of prescriptions, over-the-counter products, supplements, alcohol, and other substances. Ask about interactions and instructions specific to your regimen. Do not stop an antidepressant, change a sedating medicine, or adjust ketamine on your own.
How do we assess progress?
Agree on goals, follow-up timing, and what to do if symptoms worsen. Brief notes about mood, sleep, daily activities, and unwanted effects can help. The strength of a dissociative experience is not a reliable measure of treatment benefit.
What if I need help between appointments?
Ask for a clear contact plan, including what is available outside office hours and what requires urgent care. Email and routine scheduling are not emergency services. For difficulty breathing, unconsciousness, or immediate danger, call 911.
Before any treatment decision, make sure you understand alternatives and practical requirements, including restrictions on driving and activities requiring alertness. A clinician should assess whether the proposed setting is appropriate for you rather than assuming home use is suitable for everyone.
Risks and the treatment setting
Ketamine can cause sedation, dissociation, impaired thinking or coordination, increased blood pressure, and slowed breathing. Abuse, misuse, dependence, worsening psychiatric symptoms, and urinary or bladder problems are additional concerns. A prescription or lower dose does not eliminate these risks.
At home, a healthcare professional is not onsite to monitor you or respond immediately to a serious reaction. Virtual visits and follow-up support do not provide the same monitoring as an onsite healthcare team. Discuss your medications, health history, monitoring needs, and emergency plan with your clinician.
Discuss your options
Bliss Mist Rx LLC provides telehealth services and does not compound or manufacture medications. A licensed clinician determines whether treatment is appropriate. A consultation does not guarantee a prescription. If prescribed, medication is dispensed by an independent, appropriately licensed compounding pharmacy.
Book a Free Virtual Appointment or Follow-Up.
This article is general education and does not replace individualized medical advice.
